Trades on 1 secondary market

Vima Therapeutics

Vima Therapeutics is a clinical-stage biotechnology company developing novel oral therapies for movement disorders, with a focus on the underlying biology of dystonia and Parkinson's disease. Its lead program is an experimental oral therapy being evaluated in the Stride dystonia clinical study, aime

minimal 5.7 / 100 0 APIs View provider profile →

Company Biotechnology Therapeutics Movement Disorders Dystonia Parkinson's Disease

Vima Therapeutics is an API provider whose private shares are listed on 1 secondary market: Nasdaq Private Market.

Where It Trades

N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.